International Business Machines Corporation - IBM

IBM Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
IBM	1.0	2.3	0.6	-3.0	22.7	30.1	73.8	69.1	54.7	2983.5
S&P 500	1.0	0.6	1.1	2.4	8.9	23.6	36.4	80.6	195.1	33856.2

Compare IBM with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	IBM
name	International Business Machines Corporation
price	224.79
changes percentage	0.9566
change	2.13
day low	223.66
day high	225.955
year high	239.35
year low	162.62
market cap	207850949550
price avg 50	221.585
price avg 200	198.84454
exchange	NYSE
volume	5470839
avg volume	4103437
open	225.955
previous close	222.66
eps	6.86
pe	32.77
earnings announcement	2025-01-29T21:00:00.000+0000
shares outstanding	924645000
timestamp	2025-01-17 21:00:02

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 59.7%

Overall Quarterly Financial Health: 28.3%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000051143
revenue	61860000000	60530000000	2.20
gross profit	34300000000	32687000000	4.93
gross profit ratio	0.55	0.54	2.68
research and development expenses	6775000000	6567000000	3.17
operating expenses	25257000000	24513000000	3.04
interest income	670000000	162000000	313.58
interest expense	1607000000	1216000000	32.15
ebitda	14560000000	6853000000	112.46
ebitdaratio	0.24	0.12	98.59
operating income	9043000000	2372000000	281.24
operating income ratio	0.15	0.04	273.04
net income	7502000000	1640000000	357.44
net income ratio	0.12	0.03	347.60
eps	8.23	1.82	352.20

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 61,860 million in 2023 from 60,530 million in 2022 representing a change of 2.2%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 34,300 million in 2023 from 32,687 million in 2022 representing a change of 4.93%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 6,775 million in 2023 from 6,567 million in 2022 representing a change of 3.17%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 9,043 million in 2023 from 2,372 million in 2022 representing a change of 281.24%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 7,502 million in 2023 from 1,640 million in 2022 representing a change of 357.44%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 8.23 in 2023 from 8.23 in 2022 representing a change of 352.2%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 25,257 million in 2023 from 24,513 million in 2022 representing a change of 3.04%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 14,560 million in 2023 from 6,853 million in 2022 representing a change of 112.46%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000051143
revenue	14967000000	15770000000	-5.09
gross profit	8419000000	8574000000	-1.81
gross profit ratio	0.56	0.54	3.46
research and development expenses	1876000000	1840000000	1.96
operating expenses	6787000000	5939000000	14.28
interest income	170000000	217000000	-21.66
interest expense	429000000	427000000	0.47
ebitda	1042000000	3751000000	-72.22
ebitdaratio	0.07	0.24	-71.03
operating income	1871000000	2635000000	-28.99
operating income ratio	0.13	0.17	-25.18
net income	-330000000	1834000000	-117.99
net income ratio	-0.02	0.12	-118.96
eps	-0.36	1.99	-118.09

Overall Score of Quarterly Income Statement

0.12 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 14,967 million in 2024Q3 from 15,770 million in 2024Q2 representing a change of -5.09%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 8,419 million in 2024Q3 from 8,574 million in 2024Q2 representing a change of -1.81%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 6,787 million in 2024Q3 from 5,939 million in 2024Q2 representing a change of 14.28%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,042 million in 2024Q3 from 3,751 million in 2024Q2 representing a change of -72.22%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to 1,871 million in 2024Q3 from 2,635 million in 2024Q2 representing a change of -28.99%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -330 million in 2024Q3 from 1,834 million in 2024Q2 representing a change of -117.99%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to -0.36 in 2024Q3 from -0.36 in 2024Q2 representing a change of -118.09%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 1,876 million in 2024Q3 from 1,840 million in 2024Q2 representing a change of 1.96%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000051143
total assets	135241000000	127243000000	6.29
total liabilities	112628000000	105222000000	7.04
total equity	22613000000	22021000000	2.69
cash and cash equivalents	13068000000	7886000000	65.71
short term investments	373000000	852000000	-56.22
long term investments	5961000000	1617000000	268.65
total current assets	32908000000	29118000000	13.02
total non current assets	102333000000	98126000000	4.29
total current liabilities	34122000000	31505000000	8.31
total non current liabilities	78506000000	73717000000	6.50
common stock	59643000000	58343000000	2.23
retained earnings	151276000000	149825000000	0.97
total debt	59935000000	54013000000	10.96

Overall Score of Annual Balance Sheet

0.6 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 135,241 million in 2023 from 127,243 million in 2022 representing a change of 6.29%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 22,613 million in 2023 from 22,021 million in 2022 representing a change of 2.69%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 13,068 million in 2023 from 7,886 million in 2022 representing a change of 65.71%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 32,908 million in 2023 from 29,118 million in 2022 representing a change of 13.02%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 59,643 in 2023 from 58,343 in 2022 representing a change of 2.23%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 151,276 million in 2023 from 149,825 million in 2022 representing a change of 0.97%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 112,628 million in 2023 from 105,222 million in 2022 representing a change of 7.04%. This indicates an increase in overall liabilities.

  Short Term Investments: Short Term Investments decreased to 373 million in 2023 from 852 million in 2022 representing a change of -56.22%. This indicates a decrease in short-term investment holdings.

  Total Current Liabilities: Total Current Liabilities increased to 34,122 million in 2023 from 31,505 million in 2022 representing a change of 8.31%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 59,935 million in 2023 from 54,013 million in 2022 representing a change of 10.96%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000051143
total assets	134339000000	133848000000	0.37
total liabilities	109809000000	109744000000	0.06
total equity	24530000000	24103000000	1.77
cash and cash equivalents	13197000000	14478000000	-8.85
short term investments	505000000	1481000000	-65.90
long term investments	5079000000	5599000000	-9.29
total current assets	29577000000	32302000000	-8.44
total non current assets	104762000000	101546000000	3.17
total current liabilities	28853000000	29648000000	-2.68
total non current liabilities	80956000000	80096000000	1.07
common stock	61013000000	60501000000	0.85
retained earnings	149789000000	151659000000	-1.23
total debt	60126000000	59839000000	0.48

Overall Score of Quarterly Balance Sheet

0.4 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 134,339 million in 2024Q3 from 133,848 million in 2024Q2 representing a change of 0.37%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 24,530 million in 2024Q3 from 24,103 million in 2024Q2 representing a change of 1.77%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 28,853 million in 2024Q3 from 29,648 million in 2024Q2 representing a change of -2.68%. This indicates a lower short-term debt burden.

  Common Stock: Common Stock increased to 61,013 in 2024Q3 from 60,501 in 2024Q2 representing a change of 0.85%. This indicates an increase in ownership interest.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 109,809 million in 2024Q3 from 109,744 million in 2024Q2 representing a change of 0.06%. This indicates an increase in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 13,197 million in 2024Q3 from 14,478 million in 2024Q2 representing a change of -8.85%. This indicates a decrease in available liquid assets.

  Short Term Investments: Short Term Investments decreased to 505 million in 2024Q3 from 1,481 million in 2024Q2 representing a change of -65.9%. This indicates a decrease in short-term investment holdings.

  Total Current Assets: Total Current Assets decreased to 29,577 million in 2024Q3 from 32,302 million in 2024Q2 representing a change of -8.44%. This indicates a worsen liquidity position.

  Retained Earnings: Retained Earnings decreased to 149,789 million in 2024Q3 from 151,659 million in 2024Q2 representing a change of -1.23%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 60,126 million in 2024Q3 from 59,839 million in 2024Q2 representing a change of 0.48%. This indicates an increase in overall debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000051143
net change in cash	5101000000	1031000000	394.76
operating cash flow	13931000000	10435000000	33.50
free cash flow	12121000000	8575000000	41.35
capital expenditure	-1810000000	-1860000000	2.69
depreciation and amortization	4396000000	4802000000	-8.45
deferred income tax	-1114000000	-2726000000	59.13
stock based compensation	1133000000	987000000	14.79
accounts payables	65000000	213000000	-69.48
inventory	390000000	71000000	449.30
acquisitions net	-5082000000	-1076000000	-372.30
investments in property plant and equipment	-1245000000	-1860000000	33.06
net cash used for investing activites	-7070000000	-4202000000	-68.25
debt repayment	4497000000	1221000000	268.30
common stock issued	0	0	NaN
common stock repurchased	-402000000	-407000000	1.23
dividends paid	-6040000000	-5948000000	-1.55
net cash used provided by financing activities	-1769000000	-4958000000	64.32
cash at end of period	13089000000	7988000000	63.86
accounts receivables	725000000	-717000000	201.12
cash at beginning of period	7988000000	6957000000	14.82

Overall Score of Annual Cashflow Statement

0.44 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 5,101 million in 2023 from 1,031 million in 2022 representing a change of 394.76%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 13,931 million in 2023 from 10,435 million in 2022 representing a change of 33.5%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 12,121 million in 2023 from 8,575 million in 2022 representing a change of 41.35%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 65 million in 2023 from 213 million in 2022 representing a change of -69.48%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -1,810 million in 2023 from -1,860 million in 2022 representing a change of 2.69%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to -1,114 million in 2023 from -2,726 million in 2022 representing a change of 59.13%. This indicates that the company's tax liability for future periods has increased.

  Stock-Based Compensation: Stock-Based Compensation increased to 1,133 million in 2023 from 987 million in 2022 representing a change of 14.79%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Accounts Receivables: Accounts Receivables increased to 725 in 2023 from -717 million in 2022 representing a change of 201.12%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -6,040 million in 2023 from -5,948 million in 2022 representing a change of -1.55%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000051143
operating cash flow	2881000000	2066000000	39.45
free cash flow	2457000000	1622000000	51.48
capital expenditure	-424000000	-444000000	4.50
depreciation and amortization	1268000000	1155000000	9.78
deferred income tax	0	0	NaN
stock based compensation	330000000	316000000	4.43
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	-2511000000	-108000000	-2225.00
investments in property plant and equipment	-424000000	-444000000	4.50
net cash used for investing activites	-1587000000	2239000000	-170.88
debt repayment	-1258000000	-2900000000	56.62
common stock issued	0	0	NaN
common stock repurchased	-189000000	-151000000	-25.17
dividends paid	-1543000000	-1536000000	-0.46
net cash used provided by financing activities	-2765000000	-4515000000	38.76
net change in cash	-1264000000	-287000000	-340.42
cash at end of period	13214000000	14478000000	-8.73
cash at beginning of period	14478000000	14765000000	-1.94

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to -1,264 million in 2024Q3 from -287 million in 2024Q2 representing a change of -340.42%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to -424 million in 2024Q3 from -444 million in 2024Q2 representing a change of 4.5%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Stock-Based Compensation: Stock-Based Compensation increased to 330 million in 2024Q3 from 316 million in 2024Q2 representing a change of 4.43%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.

  Dividends Paid: Dividends Paid decreased to -1,543 million in 2024Q3 from -1,536 million in 2024Q2 representing a change of -0.46%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 2,881 million in 2024Q3 from 2,066 million in 2024Q2 representing a change of 39.45%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 2,457 million in 2024Q3 from 1,622 million in 2024Q2 representing a change of 51.48%. This indicates an increase in cash generated after accounting for capital expenditures.

Earnings Transcripts ⓘ

We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.

Note: The years mentioned below are fiscal years in accounting.

Q3 2024 Earnings call transcript
Q2 2024 Earnings call transcript
Q1 2024 Earnings call transcript
Q4 2023 Earnings call transcript
Q3 2023 Earnings call transcript
Q2 2023 Earnings call transcript
Q1 2023 Earnings call transcript
Q4 2022 Earnings call transcript

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	67.89	67.06	1.24
net income per share	8.23	1.82	353.15
operating cash flow per share	15.29	11.56	32.25
free cash flow per share	13.3	9.5	40.03
cash per share	14.75	9.68	52.38
book value per share	24.82	24.4	1.73
tangible book value per share	-53.34	-49.98	-6.72
shareholders equity per share	24.73	24.31	1.72
interest debt per share	67.54	61.18	10.39
market cap	149028447672.45	127176357729.1	17.18
enterprise value	195895447672.45	173303357729.1	13.04
pe ratio	19.87	77.55	-74.38
price to sales ratio	2.41	2.1	14.66
pocfratio	10.7	12.19	-12.22
pfcf ratio	12.3	14.83	-17.10
pb ratio	6.61	5.8	14.12
ptb ratio	6.61	5.8	14.12
ev to sales	3.17	2.86	10.61
enterprise value over ebitda	13.45	25.29	-46.80
ev to operating cash flow	14.06	16.61	-15.33
ev to free cash flow	16.16	20.21	-20.03
earnings yield	0.05	0.01	290.36
free cash flow yield	0.08	0.07	20.63
debt to equity	2.66	2.46	8.06
debt to assets	0.44	0.42	4.40
net debt to ebitda	3.22	6.73	-52.18
current ratio	0.96	0.92	4.35
interest coverage	5.63	1.95	188.48
income quality	1.86	6.37	-70.83
dividend yield	0.04	0.05	-13.34
payout ratio	0.81	3.63	-77.80
sales general and administrative to revenue	0.28	0.27	4.46
research and ddevelopement to revenue	0.11	0.11	0.95
intangibles to total assets	0.53	0.53	-0.19
capex to operating cash flow	0.13	0.18	-27.11
capex to revenue	0.03	0.03	-4.78
capex to depreciation	0.41	0.39	6.30
stock based compensation to revenue	0.02	0.02	12.32
graham number	67.68	31.52	114.70
roic	0.07	0.04	100.05
return on tangible assets	0.12	0.03	329.45
graham net net	-101.86	-100.21	-1.65
working capital	-1214000000	-2387000000	49.14
tangible asset value	-48601000000	-45112000000	-7.73
net current asset value	-79720000000	-76104000000	-4.75
invested capital	78721000000	72958000000	7.90
average receivables	7362000000	7115000000	3.47
average payables	4091500000	4003000000	2.21
average inventory	1356500000	1600500000	-15.25
days sales outstanding	45.55	42.24	7.82
days payables outstanding	54.72	53.11	3.05
days of inventory on hand	15.38	20.35	-24.43
receivables turnover	8.01	8.64	-7.26
payables turnover	6.67	6.87	-2.96
inventory turnover	23.74	17.94	32.32
roe	0.33	0.07	345.48
capex per share	1.99	2.06	-3.60

• Positive

  ROE: Return on Equity (ROE) increased to 0.33 on 2023-12-31 from 0.07 on 2022-12-31, representing a change of 345.48%. Suggesting the company has been generating high returns for its shareholders.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 19.87 on 2023-12-31 from 77.55 on 2022-12-31, representing a change of -74.38%. Indicating a decrease in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 0.96 on 2023-12-31 from 0.92 on 2022-12-31, representing a change of 4.35%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 2.66 on 2023-12-31 from 2.46 on 2022-12-31, representing a change of 8.06%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. A ratio of 2.0 or higher is usually considered risky.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
IBM
calendar year	2024	2024	NaN
revenue per share	16.26	17.14	-5.09
net income per share	-0.36	1.99	-117.99
operating cash flow per share	3.13	2.24	39.45
free cash flow per share	2.67	1.76	51.48
cash per share	14.89	17.34	-14.14
book value per share	26.65	26.19	1.77
tangible book value per share	-51.78	-49.51	-4.58
shareholders equity per share	26.57	26.11	1.76
interest debt per share	65.8	65.49	0.48
market cap	203459924000	161142348429.1	26.26
enterprise value	250388924000	206503348429.1	21.25
pe ratio	-154.14	21.97	-801.71
price to sales ratio	13.59	10.22	33.04
pocfratio	70.62	78.0	-9.46
pfcf ratio	82.81	99.35	-16.65
pb ratio	8.32	6.71	24.08
ptb ratio	8.32	6.71	24.08
ev to sales	16.73	13.09	27.76
enterprise value over ebitda	240.3	55.05	336.48
ev to operating cash flow	86.91	99.95	-13.05
ev to free cash flow	101.91	127.31	-19.96
earnings yield	-0.0	0.01	-114.25
free cash flow yield	0.01	0.01	19.97
debt to equity	2.46	2.49	-1.25
debt to assets	0.45	0.45	0.11
net debt to ebitda	45.04	12.09	272.42
current ratio	1.03	1.09	-5.91
interest coverage	4.36	6.17	-29.33
income quality	-9.73	1.13	-962.13
dividend yield	0.01	0.01	-20.44
payout ratio	-4.68	0.84	-658.29
sales general and administrative to revenue	0.29	0.27	5.98
research and ddevelopement to revenue	0.13	0.12	7.43
intangibles to total assets	0.54	0.52	3.23
capex to operating cash flow	0.15	0.21	-31.52
capex to revenue	0.03	0.03	0.62
capex to depreciation	0.33	0.38	-13.01
stock based compensation to revenue	0.02	0.02	10.03
graham number	14.64	34.21	-57.21
roic	0.01	0.02	-66.38
return on tangible assets	-0.01	0.03	-118.58
graham net net	-93.37	-96.1	2.83
working capital	724000000	2654000000	-72.72
tangible asset value	-47652000000	-45563000000	-4.58
net current asset value	-80232000000	-77442000000	-3.60
invested capital	81875000000	81051000000	1.02
average receivables	9482000000	9579000000	-1.01
average payables	3452500000	3609500000	-4.35
average inventory	1300500000	1223000000	6.34
days sales outstanding	76.1	36.01	111.35
days payables outstanding	45	45.41	-0.91
days of inventory on hand	18.79	15.43	21.74
receivables turnover	1.18	2.5	-52.68
payables turnover	2	1.98	0.92
inventory turnover	4.79	5.83	-17.86
roe	-0.01	0.08	-117.68
capex per share	0.46	0.48	-4.51

• Negative

  ROE: Return on Equity (ROE) decreased to -0.01 on 2024-09-30 Q3 from 0.08 on 2024-06-30 Q2, representing a change of -117.68%. Suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -154.14 on 2024-09-30 Q3 from 21.97 on 2024-06-30 Q2, representing a change of -801.71%. Indicating a decrease in the relative valuation of the company's stock.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 2.46 on 2024-09-30 Q3 from 2.49 on 2024-06-30 Q2, representing a change of -1.25%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. However, a ratio of 2.0 or higher is usually considered risky.

• Neutral

  Current Ratio: Current Ratio decreased to 1.03 on 2024-09-30 Q3 from 1.09 on 2024-06-30 Q2, representing a change of -5.91%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 224.17 which is lower than current price 224.79, indicates the company may be overvalued.